Catarina Falcão de Campos

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy

David Adams, Jonas Wixner, Michael Polydefkis et al. · JAMA Neurology · 2025 · 31 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease

Riccardo Curró, Natalia Dominik, Stefano Facchini et al. · Brain · 2024 · 28 citations · Full text

Life Sciences, Biostatistics, Aging +12

Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries

Catarina Falcão de Campos, Marta Gromicho, Hilmi Uysal et al. · Frontiers in Neurology · 2023 · 27 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Delayed Diagnosis and Diagnostic Pathway of ALS Patients in Portugal: Where Can We Improve?

Catarina Falcão de Campos, Marta Gromicho, Hilmi Uysal et al. · Frontiers in Neurology · 2021 · 26 citations · Full text

Medicine, Neurology, Neuroscience +16